Evan Judd

Evan Judd is a highly experienced scientist with a Ph.D. in Molecular and Cell Biology, and Biochemistry. They have worked at Novartis, Agios Pharmaceuticals, Boston University, and the University of North Florida in various research and teaching roles. Evan currently holds the position of Senior Principal Scientist at Novartis, leading a small molecule oncology drug discovery program. Prior to this, they focused on small-molecule drug discovery targeting enzymes/proteins important in cancer and rare genetic diseases. Their research interests include biochemistry, enzymology, and biophysics, with a strong background in understanding the function of proteins and enzymes involved in cancer.